Receptores cannabinoides y vías de modulación del dolor.

Autores:: Castro Barragán, José
Daniels García, María
Martínez Visbal, Alfonso

Tipo de recurso:: Article of journal

Fecha de publicación:: 2015

Institución:: Universidad de Cartagena

Repositorio:: Repositorio Universidad de Cartagena

Idioma:: spa

id	UCART2_0cfcccbdb97e05412cb3f643d9e78b65
oai_identifier_str	oai:repositorio.unicartagena.edu.co:11227/13167
network_acronym_str	UCART2
network_name_str	Repositorio Universidad de Cartagena
repository_id_str
dc.title.spa.fl_str_mv	Receptores cannabinoides y vías de modulación del dolor.
dc.title.translated.eng.fl_str_mv	Cannabinoid receptors and pain modulation pathways.
title	Receptores cannabinoides y vías de modulación del dolor.
spellingShingle	Receptores cannabinoides y vías de modulación del dolor. Endocannabinoides Tetrahidrocannabinol Modulación antigénica Endocannabinoids Tetrahydrocannabinol Antigenic modulation
title_short	Receptores cannabinoides y vías de modulación del dolor.
title_full	Receptores cannabinoides y vías de modulación del dolor.
title_fullStr	Receptores cannabinoides y vías de modulación del dolor.
title_full_unstemmed	Receptores cannabinoides y vías de modulación del dolor.
title_sort	Receptores cannabinoides y vías de modulación del dolor.
dc.creator.fl_str_mv	Castro Barragán, José Daniels García, María Martínez Visbal, Alfonso
dc.contributor.author.spa.fl_str_mv	Castro Barragán, José Daniels García, María Martínez Visbal, Alfonso
dc.subject.spa.fl_str_mv	Endocannabinoides Tetrahidrocannabinol Modulación antigénica
topic	Endocannabinoides Tetrahidrocannabinol Modulación antigénica Endocannabinoids Tetrahydrocannabinol Antigenic modulation
dc.subject.eng.fl_str_mv	Endocannabinoids Tetrahydrocannabinol Antigenic modulation
publishDate	2015
dc.date.issued.none.fl_str_mv	2015-01-01
dc.date.accessioned.none.fl_str_mv	2016-01-01 00:00:00
dc.date.available.none.fl_str_mv	2016-01-01 00:00:00
dc.type.spa.fl_str_mv	Artículo de revista
dc.type.coar.fl_str_mv	http://purl.org/coar/resource_type/c_2df8fbb1
dc.type.version.spa.fl_str_mv	info:eu-repo/semantics/publishedVersion
dc.type.coarversion.spa.fl_str_mv	http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.coar.spa.fl_str_mv	http://purl.org/coar/resource_type/c_6501
dc.type.content.spa.fl_str_mv	Text
dc.type.driver.spa.fl_str_mv	info:eu-repo/semantics/article
dc.type.local.eng.fl_str_mv	Journal article
format	http://purl.org/coar/resource_type/c_6501
status_str	publishedVersion
dc.identifier.issn.none.fl_str_mv	2215-7840
dc.identifier.doi.none.fl_str_mv	10.32997/rcb-2016-2935
dc.identifier.eissn.none.fl_str_mv	2389-7252
dc.identifier.url.none.fl_str_mv	https://doi.org/10.32997/rcb-2016-2935
identifier_str_mv	2215-7840 10.32997/rcb-2016-2935 2389-7252
url	https://doi.org/10.32997/rcb-2016-2935
dc.language.iso.spa.fl_str_mv	spa
language	spa
dc.relation.ispartofjournal.spa.fl_str_mv	Revista Ciencias Biomédicas
dc.relation.bitstream.none.fl_str_mv	https://revistas.unicartagena.edu.co/index.php/cbiomedicas/article/download/2935/2470
dc.relation.citationedition.spa.fl_str_mv	Núm. 1 , Año 2016
dc.relation.citationendpage.none.fl_str_mv	103
dc.relation.citationissue.spa.fl_str_mv	1
dc.relation.citationstartpage.none.fl_str_mv	93
dc.relation.citationvolume.spa.fl_str_mv	7
dc.relation.references.spa.fl_str_mv	Freund TF, Katona I, Piomelli D. Role of endogenous cannabinoids in synaptic signaling. Physiol Rev 2003; 83:1017-66. https://doi.org/10.1152/physrev.00004.2003 Matsuda LA, Lolait, SJ, Brownstein MJ, Young AC, Bonner TI. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature. 1990;346(6284):561-4. https://doi.org/10.1038/346561a0 Muccioli GG. Endocannabinoid biosynthesis and inactivation, from simple to complex. Drug Discov Today. 2010;15(11-12):474-83. https://doi.org/10.1016/j.drudis.2010.03.007 Howlett AC, Johnson MR, Melvin LS, Milne GM. Nonclassical cannabinoid analgetics inhibit adenylate cyclase: development of a cannabinoid receptor model. Mol Pharmacol. 1988;33(3):297-302. Munro S, Thomas K.L, Abu-Shaar M. Molecular characterization of a peripheral receptor for cannabinoids. Nature. 1993;365(6441):61-65. https://doi.org/10.1038/365061a0 Díaz I. Mecanismo de transducción de señal de los cannabinoides. Sociedad Española de investigación sobre cannabinoides (SEIC) 2002.Pp 44-45. Alvarez J, Palmer J. The role of endocannabinoids in pain modulation and the therapeutic potential of inhibiting their enzymatic degradation. Current pharmaceutical biotechnology. 2011;12:1644-59. https://doi.org/10.2174/138920111798357357 Howlett AC, Barth F, Bonner TI, Cabral G, Casellas P, Devane WA, Felder CC, Herkenham M, Mackie K, Martin BR, Mechoulam R, Pertwee RG. International union of pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol Rev 2002;54:161-202. https://doi.org/10.1124/pr.54.2.161 Hohmann, A. G, Herkenham M. Neurosci. Lett. 1998;252:13-16. https://doi.org/10.1016/S0304-3940(98)00534-5 Rodríguez U, Carrillo E. Cannabinoides: neurobiología y usos médicos. Elementos. 2005;12(60):3. Farmacología de los receptores para cannabinoides; Sociedad Española de Investigación sobre Cannabinoides (SEIC) Departamento de Bioquímica y Biología Molecular Facultad de Medicina Universidad Complutense de Madrid 28040 Madrid. Degenhardt L, Hall W. Extent of illicit drug use and dependence, and their contribution to the global burden of disease. Lancet 2012;379:55-70. https://doi.org/10.1016/S0140-6736(11)61138-0 Fine P, Rosenfeld M. The Endocannabinoid System, Cannabinoids, and Pain. Rambam Maimonides Medical Journal. 2013;4:4: e0022. https://doi.org/10.5041/RMMJ.10129 1Ware M, Desroches J. Cannabis medicinal y dolor. Pain: Clinical Updates. 2014;22: 1 -10. Volkow N, Baler R. Adverse Health Effects of Marijuana Use. N Engl J Med 2014;370:2219-27. https://doi.org/10.1056/NEJMra1402309 Actualización sobre el potencial terapéutico de los cannabinoides; Sociedad Española de Investigación sobre Cannabinoides (SEIC) Departamento de Bioquímica y Biología Molecular Facultad de Medicina Universidad Complutense de Madrid 28040 Madrid. Pertwee R. The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: Δ9-tetrahydrocannabinol, cannabidiol and Δ9-tetrahydrocannabivarin. Br J Pharmacol. 2008;153(2):199-215. https://doi.org/10.1038/sj.bjp.0707442 Casadiego A, Lastra S. Cannabis sintético: aspectos toxicológicos, usos clínicos y droga de diseño. Rev. Fac. Med. 2015;63(3): 501-10. https://doi.org/10.15446/revfacmed.v63n3.47460 González S, Sagredo O, Gómez M, Ramos JA. Química y metabolismo de los cannabinoides. En: Sociedad Española de Investigación Sobre Cannabinoides. Guía básica sobre los cannabinoides. Madrid: Universidad Complutense de Madrid; 2009. p. 13-22. Pertwee R. The diverse CB1 and CB2 receptor pharmacology of threeplant cannabinoids: Δ9-tetrahydrocannabinol, cannabidiol and Δ9-tetrahydrocannabivarin. Br J Pharmacol. 2008;153(2):199-215. https://doi.org/10.1038/sj.bjp.0707442 Fine P, Rosenfeld M. The Endocannabinoid System, Cannabinoids, and Pain. Rambam Maimonides Med J. 2013;4(4): e0022. https://doi.org/10.5041/RMMJ.10129 Guzmán M. Galve-Roperh I. Endocannabinoides: un nuevo sistema de comunicación en el cerebro. Farmacia.2010;11:173-79. https://doi.org/10.18567/sebbmdiv_ANC.2010.11.1 Netzahualcoyotzi, C. Muñoz, N. Martínez, I. Florán, B. Limón, D. La marihuana y el sistema endocanabinoide: de sus efectos recreativos a la terapéutica. Rev Biomed. 2009;20:128-153. Whitlow, C. Freedland, C. Porrino, L. Functional consequences of the repeated administration of Delta9-tetrahydrocannabinol in the rat. Drug Alcohol Depend. 2003;71:169-77. https://doi.org/10.1016/S0376-8716(03)00135-2 Murillo, E. Drucker, R. Endocanabinoides y su modulación en el sueño. Arch Neurocien, México. 2006:11(3): 185-93. Svíženská I, Dubový P, Šulcová A. Cannabinoid receptors 1 and 2 (CB1 and CB2), their distribution, ligands and functional involvement in nervous system structures - A short review. Pharmacol Biochem Behav. 2008;90(4):501-11. https://doi.org/10.1016/j.pbb.2008.05.010 Abood ME, Martin BR. Molecular neurobiology of the cannabinoid receptor. International Review of Neurobiology. 1996;39:197-221. https://doi.org/10.1016/S0074-7742(08)60667-4 Society for Neuroscience. Cannabinoids and animal physiology. 1998. Palazzo E, Luongo L, Novelli V. The role of cannabinoid receptors in the descending modulation of pain. Pharmaceuticals (Basel). 2010;3(8):2661-73. https://doi.org/10.3390/ph3082661 Bequet, F., Uzabiaga, F., Desbazeille, M., Ludwiczak, P., Maftouh, M., Picard, C., Scatton, B. & Le Fur, G. CB1 receptor-mediated control of the release of endocannabinoids (as assessed by microdialysis coupled with LC/MS) in the rat hypothalamus.Eur. J. Neurosci. 2007;26:3458-64. https://doi.org/10.1111/j.1460-9568.2007.05900.x 18. Croci T, Manara L, Aureggi G, Guagnini F, Rinaldi-Carmona M, Maffrand JP, et al. In vitro functional evidence of neuronal cannabinoid CB1 receptors in human ileum. Br J Pharmacol 1998;125:1393-5. https://doi.org/10.1038/sj.bjp.0702190 Hasanein P, Parviz M, Keshavarz M, Javanmardi K. CB1 receptor activation in the basolateral amygdala produces antinociception in animal models of acute and tonic nociception. Clin Exp Pharmacol Physiol. 2007;34(5-6):439-49. https://doi.org/10.1111/j.1440-1681.2007.04592.x Flores. A., Maldonado R., Berrendero F. Cannabinoid-hypocretin cross-talk in the central nervous system: what we know so far. Journal Neuroscience. 2013;7:256. https://doi.org/10.3389/fnins.2013.00256 Neubert MJ, Kincaid W, Heinricher MM. Nociceptive facilitating neurons in the rostral ventromedial medulla. Pain. 2004;110:158-165. https://doi.org/10.1016/j.pain.2004.03.017 Starowicz K., Malek N., Przewlocka B. Cannabinoid receptors and pain. Focus Article. 2013;2:15-20. https://doi.org/10.1002/wmts.83 Shu-Jung Hu S. Cheng Ho Y., Chu Chiou L. No more pain upon Gq-protein-coupled receptor activation: role of endocannabinoids. European Journal of Neuroscience.2014;39: 467-84. https://doi.org/10.1111/ejn.12475 Russo E., Hohmann A. Role of cannabinoids in pain management. GW Pharmaceuticals. Ther Clin Risk Manag. 2008;4(1):245-259. https://doi.org/10.2147/TCRM.S1928 Mangieri RA, Piomelli D. Enhancement of endocannabinoid signaling and the pharmacotherapy of depression. Pharmacol Res. 2007;56(5):360-6. https://doi.org/10.1016/j.phrs.2007.09.003 Gulyas AI, Cravatt BF, Bracey MH, et al. Segregation of two endocannabinoid- hydrolyzing enzymes into pre- and postsynaptic compartments in the rat hippocampus, cerebellum and amygdala. Eur J Neurosci. 2004;20(2):441-58. https://doi.org/10.1111/j.1460-9568.2004.03428.x Neubert MJ, Kincaid W, Heinricher MM. Nociceptive facilitating neurons in the rostral ventromedial medulla. Pain. 2004;110:158-65. https://doi.org/10.1016/j.pain.2004.03.017 Durnett J. Cannabinoids Modulate Pain by Multiple Mechanisms of Action. The Journal of Pain. 2000;1(1): 2-14. https://doi.org/10.1016/S1526-5900(00)90082-8 Walker M, Huang S, Strangman N. Pain modulation by release of the endogenous cannabinoid anandamide. Rev. Psychology.1999;96(21): 14-25. https://doi.org/10.1073/pnas.96.21.12198 Rodríguez U, Carrillo E. Cannabinoides: neurobiología y usos médicos. Elementos.2005;60(12):3 De Novellis V, Mariani L, Palazzo E, VitaD, Marabese I, Scafuro M, Rossi F, Maione S. Periaqueductal grey CB1 cannabinoid and metabotropic glutamate subtype 5 receptors modulate changes in rostral ventromedial medulla neuronal activities induced by subcutaneous formalin in the rat. Neuroscience 2005;134: 269-281. https://doi.org/10.1016/j.neuroscience.2005.03.014 Rea K, Roche M, Finn D. Supraspinal modulation of pain by cannabinoids: the role of GABA and glutamate. British Journal of Pharmacology .2007;152:633-648. https://doi.org/10.1038/sj.bjp.0707440
dc.rights.spa.fl_str_mv	Revista Ciencias Biomédicas - 2016
dc.rights.uri.spa.fl_str_mv	https://creativecommons.org/licenses/by-nc-sa/4.0
dc.rights.coar.spa.fl_str_mv	http://purl.org/coar/access_right/c_abf2
dc.rights.accessrights.spa.fl_str_mv	info:eu-repo/semantics/openAccess
rights_invalid_str_mv	Revista Ciencias Biomédicas - 2016 https://creativecommons.org/licenses/by-nc-sa/4.0 http://purl.org/coar/access_right/c_abf2
eu_rights_str_mv	openAccess
dc.format.mimetype.spa.fl_str_mv	application/pdf
dc.publisher.spa.fl_str_mv	Universidad de Cartagena
dc.source.spa.fl_str_mv	https://revistas.unicartagena.edu.co/index.php/cbiomedicas/article/view/2935
institution	Universidad de Cartagena
bitstream.url.fl_str_mv	https://repositorio.unicartagena.edu.co/bitstreams/a83f818c-ea91-4533-b425-18fd6945808a/download
bitstream.checksum.fl_str_mv	29ff64ded0d31259ed895403aa1a8950
bitstream.checksumAlgorithm.fl_str_mv	MD5
repository.name.fl_str_mv	Biblioteca Digital Universidad de Cartagena
repository.mail.fl_str_mv	bdigital@metabiblioteca.com
_version_	1818153232402219008
spelling	Castro Barragán, JoséDaniels García, MaríaMartínez Visbal, Alfonso2016-01-01 00:00:002016-01-01 00:00:002015-01-012215-784010.32997/rcb-2016-29352389-7252https://doi.org/10.32997/rcb-2016-2935application/pdfspaUniversidad de CartagenaRevista Ciencias Biomédicashttps://revistas.unicartagena.edu.co/index.php/cbiomedicas/article/download/2935/2470Núm. 1 , Año 20161031937Freund TF, Katona I, Piomelli D. Role of endogenous cannabinoids in synaptic signaling. Physiol Rev 2003; 83:1017-66. https://doi.org/10.1152/physrev.00004.2003Matsuda LA, Lolait, SJ, Brownstein MJ, Young AC, Bonner TI. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature. 1990;346(6284):561-4. https://doi.org/10.1038/346561a0Muccioli GG. Endocannabinoid biosynthesis and inactivation, from simple to complex. Drug Discov Today. 2010;15(11-12):474-83. https://doi.org/10.1016/j.drudis.2010.03.007Howlett AC, Johnson MR, Melvin LS, Milne GM. Nonclassical cannabinoid analgetics inhibit adenylate cyclase: development of a cannabinoid receptor model. Mol Pharmacol. 1988;33(3):297-302.Munro S, Thomas K.L, Abu-Shaar M. Molecular characterization of a peripheral receptor for cannabinoids. Nature. 1993;365(6441):61-65. https://doi.org/10.1038/365061a0Díaz I. Mecanismo de transducción de señal de los cannabinoides. Sociedad Española de investigación sobre cannabinoides (SEIC) 2002.Pp 44-45.Alvarez J, Palmer J. The role of endocannabinoids in pain modulation and the therapeutic potential of inhibiting their enzymatic degradation. Current pharmaceutical biotechnology. 2011;12:1644-59. https://doi.org/10.2174/138920111798357357Howlett AC, Barth F, Bonner TI, Cabral G, Casellas P, Devane WA, Felder CC, Herkenham M, Mackie K, Martin BR, Mechoulam R, Pertwee RG. International union of pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol Rev 2002;54:161-202. https://doi.org/10.1124/pr.54.2.161Hohmann, A. G, Herkenham M. Neurosci. Lett. 1998;252:13-16. https://doi.org/10.1016/S0304-3940(98)00534-5Rodríguez U, Carrillo E. Cannabinoides: neurobiología y usos médicos. Elementos. 2005;12(60):3.Farmacología de los receptores para cannabinoides; Sociedad Española de Investigación sobre Cannabinoides (SEIC) Departamento de Bioquímica y Biología Molecular Facultad de Medicina Universidad Complutense de Madrid 28040 Madrid.Degenhardt L, Hall W. Extent of illicit drug use and dependence, and their contribution to the global burden of disease. Lancet 2012;379:55-70. https://doi.org/10.1016/S0140-6736(11)61138-0Fine P, Rosenfeld M. The Endocannabinoid System, Cannabinoids, and Pain. Rambam Maimonides Medical Journal. 2013;4:4: e0022. https://doi.org/10.5041/RMMJ.101291Ware M, Desroches J. Cannabis medicinal y dolor. Pain: Clinical Updates. 2014;22: 1 -10.Volkow N, Baler R. Adverse Health Effects of Marijuana Use. N Engl J Med 2014;370:2219-27. https://doi.org/10.1056/NEJMra1402309Actualización sobre el potencial terapéutico de los cannabinoides; Sociedad Española de Investigación sobre Cannabinoides (SEIC) Departamento de Bioquímica y Biología Molecular Facultad de Medicina Universidad Complutense de Madrid 28040 Madrid.Pertwee R. The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: Δ9-tetrahydrocannabinol, cannabidiol and Δ9-tetrahydrocannabivarin. Br J Pharmacol. 2008;153(2):199-215. https://doi.org/10.1038/sj.bjp.0707442Casadiego A, Lastra S. Cannabis sintético: aspectos toxicológicos, usos clínicos y droga de diseño. Rev. Fac. Med. 2015;63(3): 501-10. https://doi.org/10.15446/revfacmed.v63n3.47460González S, Sagredo O, Gómez M, Ramos JA. Química y metabolismo de los cannabinoides. En: Sociedad Española de Investigación Sobre Cannabinoides. Guía básica sobre los cannabinoides. Madrid: Universidad Complutense de Madrid; 2009. p. 13-22.Pertwee R. The diverse CB1 and CB2 receptor pharmacology of threeplant cannabinoids: Δ9-tetrahydrocannabinol, cannabidiol and Δ9-tetrahydrocannabivarin. Br J Pharmacol. 2008;153(2):199-215. https://doi.org/10.1038/sj.bjp.0707442Fine P, Rosenfeld M. The Endocannabinoid System, Cannabinoids, and Pain. Rambam Maimonides Med J. 2013;4(4): e0022. https://doi.org/10.5041/RMMJ.10129Guzmán M. Galve-Roperh I. Endocannabinoides: un nuevo sistema de comunicación en el cerebro. Farmacia.2010;11:173-79. https://doi.org/10.18567/sebbmdiv_ANC.2010.11.1Netzahualcoyotzi, C. Muñoz, N. Martínez, I. Florán, B. Limón, D. La marihuana y el sistema endocanabinoide: de sus efectos recreativos a la terapéutica. Rev Biomed. 2009;20:128-153.Whitlow, C. Freedland, C. Porrino, L. Functional consequences of the repeated administration of Delta9-tetrahydrocannabinol in the rat. Drug Alcohol Depend. 2003;71:169-77. https://doi.org/10.1016/S0376-8716(03)00135-2Murillo, E. Drucker, R. Endocanabinoides y su modulación en el sueño. Arch Neurocien, México. 2006:11(3): 185-93.Svíženská I, Dubový P, Šulcová A. Cannabinoid receptors 1 and 2 (CB1 and CB2), their distribution, ligands and functional involvement in nervous system structures - A short review. Pharmacol Biochem Behav. 2008;90(4):501-11. https://doi.org/10.1016/j.pbb.2008.05.010Abood ME, Martin BR. Molecular neurobiology of the cannabinoid receptor. International Review of Neurobiology. 1996;39:197-221. https://doi.org/10.1016/S0074-7742(08)60667-4Society for Neuroscience. Cannabinoids and animal physiology. 1998.Palazzo E, Luongo L, Novelli V. The role of cannabinoid receptors in the descending modulation of pain. Pharmaceuticals (Basel). 2010;3(8):2661-73. https://doi.org/10.3390/ph3082661Bequet, F., Uzabiaga, F., Desbazeille, M., Ludwiczak, P., Maftouh, M., Picard, C., Scatton, B. & Le Fur, G. CB1 receptor-mediated control of the release of endocannabinoids (as assessed by microdialysis coupled with LC/MS) in the rat hypothalamus.Eur. J. Neurosci. 2007;26:3458-64. https://doi.org/10.1111/j.1460-9568.2007.05900.x18. Croci T, Manara L, Aureggi G, Guagnini F, Rinaldi-Carmona M, Maffrand JP, et al. In vitro functional evidence of neuronal cannabinoid CB1 receptors in human ileum. Br J Pharmacol 1998;125:1393-5. https://doi.org/10.1038/sj.bjp.0702190Hasanein P, Parviz M, Keshavarz M, Javanmardi K. CB1 receptor activation in the basolateral amygdala produces antinociception in animal models of acute and tonic nociception. Clin Exp Pharmacol Physiol. 2007;34(5-6):439-49. https://doi.org/10.1111/j.1440-1681.2007.04592.xFlores. A., Maldonado R., Berrendero F. Cannabinoid-hypocretin cross-talk in the central nervous system: what we know so far. Journal Neuroscience. 2013;7:256. https://doi.org/10.3389/fnins.2013.00256Neubert MJ, Kincaid W, Heinricher MM. Nociceptive facilitating neurons in the rostral ventromedial medulla. Pain. 2004;110:158-165. https://doi.org/10.1016/j.pain.2004.03.017Starowicz K., Malek N., Przewlocka B. Cannabinoid receptors and pain. Focus Article. 2013;2:15-20. https://doi.org/10.1002/wmts.83Shu-Jung Hu S. Cheng Ho Y., Chu Chiou L. No more pain upon Gq-protein-coupled receptor activation: role of endocannabinoids. European Journal of Neuroscience.2014;39: 467-84. https://doi.org/10.1111/ejn.12475Russo E., Hohmann A. Role of cannabinoids in pain management. GW Pharmaceuticals. Ther Clin Risk Manag. 2008;4(1):245-259. https://doi.org/10.2147/TCRM.S1928Mangieri RA, Piomelli D. Enhancement of endocannabinoid signaling and the pharmacotherapy of depression. Pharmacol Res. 2007;56(5):360-6. https://doi.org/10.1016/j.phrs.2007.09.003Gulyas AI, Cravatt BF, Bracey MH, et al. Segregation of two endocannabinoid- hydrolyzing enzymes into pre- and postsynaptic compartments in the rat hippocampus, cerebellum and amygdala. Eur J Neurosci. 2004;20(2):441-58. https://doi.org/10.1111/j.1460-9568.2004.03428.xNeubert MJ, Kincaid W, Heinricher MM. Nociceptive facilitating neurons in the rostral ventromedial medulla. Pain. 2004;110:158-65. https://doi.org/10.1016/j.pain.2004.03.017Durnett J. Cannabinoids Modulate Pain by Multiple Mechanisms of Action. The Journal of Pain. 2000;1(1): 2-14. https://doi.org/10.1016/S1526-5900(00)90082-8Walker M, Huang S, Strangman N. Pain modulation by release of the endogenous cannabinoid anandamide. Rev. Psychology.1999;96(21): 14-25. https://doi.org/10.1073/pnas.96.21.12198Rodríguez U, Carrillo E. Cannabinoides: neurobiología y usos médicos. Elementos.2005;60(12):3De Novellis V, Mariani L, Palazzo E, VitaD, Marabese I, Scafuro M, Rossi F, Maione S. Periaqueductal grey CB1 cannabinoid and metabotropic glutamate subtype 5 receptors modulate changes in rostral ventromedial medulla neuronal activities induced by subcutaneous formalin in the rat. Neuroscience 2005;134: 269-281. https://doi.org/10.1016/j.neuroscience.2005.03.014Rea K, Roche M, Finn D. Supraspinal modulation of pain by cannabinoids: the role of GABA and glutamate. British Journal of Pharmacology .2007;152:633-648. https://doi.org/10.1038/sj.bjp.0707440Revista Ciencias Biomédicas - 2016https://creativecommons.org/licenses/by-nc-sa/4.0http://purl.org/coar/access_right/c_abf2info:eu-repo/semantics/openAccessEsta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-CompartirIgual 4.0.https://revistas.unicartagena.edu.co/index.php/cbiomedicas/article/view/2935EndocannabinoidesTetrahidrocannabinolModulación antigénicaEndocannabinoidsTetrahydrocannabinolAntigenic modulationReceptores cannabinoides y vías de modulación del dolor.Cannabinoid receptors and pain modulation pathways.Artículo de revistainfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/version/c_970fb48d4fbd8a85http://purl.org/coar/resource_type/c_6501http://purl.org/coar/resource_type/c_2df8fbb1Textinfo:eu-repo/semantics/articleJournal articlePublicationOREORE.xmltext/xml2490https://repositorio.unicartagena.edu.co/bitstreams/a83f818c-ea91-4533-b425-18fd6945808a/download29ff64ded0d31259ed895403aa1a8950MD5111227/13167oai:repositorio.unicartagena.edu.co:11227/131672024-09-05 15:30:42.695https://creativecommons.org/licenses/by-nc-sa/4.0Revista Ciencias Biomédicas - 2016metadata.onlyhttps://repositorio.unicartagena.edu.coBiblioteca Digital Universidad de Cartagenabdigital@metabiblioteca.com

Receptores cannabinoides y vías de modulación del dolor.

Publicaciones similares